ロード中...
Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?
Background: Anti-Xa monitoring is utilized to measure the extent of anticoagulation in certain patient populations receiving enoxaparin. It is essential to accurately obtain this pharmacodynamic marker for safe and effective anticoagulation management. Objectives: To determine the frequency of corre...
保存先:
| 出版年: | Hosp Pharm |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Thomas Land Publishers, Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5396989/ https://ncbi.nlm.nih.gov/pubmed/28439136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj5203-214 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|